NM_018671.5(UNC45A):c.62_63insAGCAGCTGGGAAGTAGCA (p.Val21_Glu22insAlaAlaGlyLysTer) AND not provided
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- May 19, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001987156.3
Allele description [Variation Report for NM_018671.5(UNC45A):c.62_63insAGCAGCTGGGAAGTAGCA (p.Val21_Glu22insAlaAlaGlyLysTer)]
NM_018671.5(UNC45A):c.62_63insAGCAGCTGGGAAGTAGCA (p.Val21_Glu22insAlaAlaGlyLysTer)
Condition(s)
- Synonyms:
- none provided
- Identifiers:
- MedGen: C3661900
-
Mus musculus ATPase type 13A2 (Atp13a2), transcript variant 4, mRNA
Mus musculus ATPase type 13A2 (Atp13a2), transcript variant 4, mRNAgi|1829661206|ref|NM_001379620.1|Nucleotide
-
PREDICTED: Mus musculus regulator of chromosome condensation 2 (Rcc2), transcrip...
PREDICTED: Mus musculus regulator of chromosome condensation 2 (Rcc2), transcript variant X2, mRNAgi|1907153798|ref|XM_006538471.4|Nucleotide
-
Mus musculus peptidyl arginine deiminase, type II (Padi2), transcript variant 2,...
Mus musculus peptidyl arginine deiminase, type II (Padi2), transcript variant 2, mRNAgi|2504581672|ref|NM_001421260.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Feb 28, 2024